🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Autoimmune Diseases

DANIsh VASculitis Database (DANIVAS) NCT05935709n/a2 sites📍 Aarhus📍 Horsens Aarhus University Hospital A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases NCT06978647Phase 11 site📍 Beijing China Immunotech (Beijing) Biotechnology Co., Ltd. · Tests: YTS109 cell Nephrotic Syndrome Study Network NCT01209000n/a44 sites📍 Los Angeles📍 Palo Alto📍 San Francisco University of Michigan · Tests: Kidney Biopsy A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care NCT06538064n/a15 sites📍 Rancho Mirage📍 San Francisco📍 New Haven Takeda · Tests: No Intervention The iLet Experience Study NCT06891898n/a1 site📍 Irvine Beta Bionics, Inc. · Tests: iLet Dosing Decision Software Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus NCT06964087Phase 25 sites📍 Birmingham📍 Walnut Creek📍 Aurora Op-T LLC · Tests: OPT101, OPT101 Placebo to Match (PTM) Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease NCT06497387EARLY Phase 11 site📍 Wuhan Tongji Hospital · Tests: PRG-1801 Clinical and Instrumental Treatment's Predictors in Subjects With Neurological Diseases Using G-EO Robotic System NCT05493514n/a1 site📍 Milan Fondazione Don Carlo Gnocchi ETS · Tests: Robotic Assisted Gait Training with G-EO system Genes and Environment in Multiple Sclerosis NCT01353547n/a5 sites📍 Bethesda📍 Boston📍 Boston Columbia University Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the Disease NCT06515106NA1 site📍 Barcelona Fundacion Clinic per a la Recerca Biomédica · Tests: Remote cognitive rehabilitation program Feasibility and Effectiveness of Tele-diabetes Remote System on Glycemic Control and Quality of Life of Children and Youth With Type 1 Diabetes NCT07828106NA1 site📍 Ramat Gan Sheba Medical Center · Tests: Tele-diabetes Remote System Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia NCT07732907n/a1 site📍 Lawrenceville Bristol-Myers Squibb · Tests: Ozanimod Twenty-four Hour Movement Behaviors and Atherosclerotic Risk NCT07774507n/a1 site📍 Presidente Prudente São Paulo State University BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site📍 Beijing Peking University People's Hospital · Tests: BCMA-CD19 CAR-T therapy Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease NCT07262476Phase 31 site📍 Shanghai Minghui Pharmaceutical (Hangzhou) Ltd · Tests: MHB018A injection Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy. NCT06733610Phase 11 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: universal allogeneic anti-CD19/BCMA CAR T-cells The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Walking, Balance, and Cognitive Functions in Individuals With Multiple Sclerosis NCT07507084NA1 site📍 Kütahya Kutahya Health Sciences University · Tests: Internal Focus Dual-Task Training, External Focus Dual-Task Training Deciphering the Genetic Architecture of Autoimmune Diseases NCT06948110n/a2 sites📍 Bethesda📍 Lima National Human Genome Research Institute (NHGRI) A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis NCT07189325Phase 31 site📍 Montpellier University Hospital, Montpellier · Tests: Platform therapies (Dimethyl Fumarate, Teriflunomide, Glatiramer Acetate, Beta-interferons), Anti-CD20 therapies (Ocrel… Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes NCT07599982NA6 sites📍 Baltimore📍 Detroit📍 Albany DreaMed Diabetes · Tests: MODI Algorithm Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL NCT07554820Phase 41 site📍 Lahore Shaikh Zayed Hospital, Lahore · Tests: Tofacitinib 5 MG Intervention for Children With Type 1 Diabetes Targeting Gut Microbes NCT06198725NA1 site📍 Shanghai Children's Hospital of Fudan University · Tests: Trimtab Follow-up Cohort of Patients With Antiphospholipid Syndrome NCT07178925n/a1 site📍 Rouen University Hospital, Rouen · Tests: Study of Antiphospholipid Syndrome responding to the Sydney classification of 2006 Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS? NCT07225868NA3 sites📍 Buffalo📍 Leiden📍 Rheinfelden Universiteit Leiden · Tests: Conscientiousness Coaching Before Cognitive Rehabilitation, Sham Intervention Before Cognitive Rehabilitation A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases NCT06980597Phase 12 sites📍 Beijing📍 Beijing Beijing GoBroad Hospital · Tests: OL-108 The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2) NCT07065968Phase 23 sites📍 Beijing📍 Beijing📍 Beijing Peking University People's Hospital · Tests: Teriflunomide, Dexamethasone " TREX1 Gene Mutations and Their Role in Systemic Lupus Erythematosus NCT07397728n/a1 site📍 Qina South Valley University · Tests: TREX1 gene polymorphisms Anifrolumab Malignancy and Serious Infections Study NCT07000110n/a4 sites📍 Copenhagen📍 Charenton-le-Pont📍 Essen AstraZeneca · Tests: Anifrolumab Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy NCT06590220n/a1 site📍 Shanghai Shanghai Changzheng Hospital
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy